• LAST PRICE
    5.6200
  • TODAY'S CHANGE (%)
    Trending Up0.3400 (6.4394%)
  • Bid / Lots
    5.6100/ 1
  • Ask / Lots
    5.6300/ 6
  • Open / Previous Close
    5.3200 / 5.2800
  • Day Range
    Low 5.1600
    High 5.6400
  • 52 Week Range
    Low 4.6200
    High 28.2600
  • Volume
    232,815
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 5.28
TimeVolumeSAGE
09:32 ET47705.32
09:33 ET5005.32
09:35 ET30755.17
09:37 ET76005.25
09:39 ET88005.245
09:42 ET9055.27
09:44 ET36005.24
09:46 ET22605.245
09:48 ET9805.26
09:50 ET5005.21
09:51 ET12035.21
09:53 ET7005.21
09:55 ET46005.255
09:57 ET15475.24
10:04 ET3685.27
10:06 ET13005.28
10:08 ET1005.28
10:09 ET4375.28
10:11 ET20005.28
10:15 ET5005.3
10:18 ET1005.3
10:20 ET92075.37
10:22 ET2005.3685
10:24 ET10005.345
10:26 ET32005.325
10:27 ET1005.325
10:29 ET33925.35
10:31 ET8285.37
10:33 ET15005.4
10:36 ET4025.43
10:38 ET3005.43
10:40 ET27565.45
10:42 ET50985.4599
10:44 ET109765.49
10:45 ET72515.498
10:47 ET41755.48
10:49 ET47515.46
10:51 ET29605.46
10:54 ET82355.52
10:56 ET40505.4802
10:58 ET4005.51
11:00 ET49335.5
11:02 ET14115.51
11:03 ET12055.54
11:05 ET8005.52
11:07 ET9005.53
11:09 ET3575.52
11:12 ET20455.52
11:14 ET24095.495
11:16 ET20145.52
11:18 ET12575.57
11:20 ET7005.58
11:21 ET14395.58
11:23 ET2005.57
11:25 ET3005.58
11:30 ET11305.58
11:32 ET6005.59
11:34 ET11005.591
11:38 ET11005.6
11:39 ET13675.635
11:41 ET3005.63
11:43 ET6485.63
11:45 ET5885.625
11:48 ET29595.6
11:50 ET1005.59
11:52 ET2005.58
11:54 ET3705.59
11:56 ET8005.62
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSAGE
SAGE Therapeutics Inc
316.3M
-1.0x
---
United StatesALEC
Alector Inc
385.9M
-1.5x
---
United StatesNKTR
Nektar Therapeutics
193.7M
-1.3x
---
United StatesPSNL
Personalis Inc
245.1M
-2.2x
---
United StatesCDXS
Codexis Inc
375.2M
-5.2x
---
United StatesYMAB
Y-mAbs Therapeutics Inc
466.3M
-20.1x
---
As of 2024-11-26

Company Information

Sage Therapeutics, Inc. is a biopharmaceutical company. The Company has developed the two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. The Company is targeting diseases and disorders of the brain across its clinical development and earlier stage pipeline. Its product ZURZUVAE is for the treatment of postpartum depression (PPD) in adults. ZURZUVAE is a neuroactive steroid that is a positive allosteric modulator of GABA receptors, targeting both synaptic and extra synaptic GABA receptors. Its product ZULRESSO (brexanolone) CIV injection is for the treatment of PPD in individuals 15 years old and older. It is also developing a portfolio of other novel compounds that target GABA receptors, including SAGE-324, which is a novel GABAA receptor positive allosteric modulator intended for chronic oral dosing. Its second area of focus for development is novel compounds that target the NMDA receptor.

Contact Information

Headquarters
215 1st StCAMBRIDGE, MA, United States 02142-1213
Phone
617-299-8380
Fax
617-299-8379

Executives

Independent Chairman of the Board
Geno Germano
President, Chief Executive Officer, Director
Barry Greene
Principal Financial Officer, Chief Operating Officer, Principal Accounting Officer, Treasurer
Christopher Benecchi
Chief Medical Officer
Laura Gault
Director
Jeffrey Jonas

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$316.3M
Revenue (TTM)
$106.4M
Shares Outstanding
61.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.88
EPS
$-5.58
Book Value
$13.32
P/E Ratio
-1.0x
Price/Sales (TTM)
3.0
Price/Cash Flow (TTM)
---
Operating Margin
-349.86%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.